Mereo BioPharma Group Plc (MREO)
0.291
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
0.291
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Total Assets (Quarterly) : 34.71M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.71M |
| March 31, 2026 | 40.61M |
| December 31, 2025 | 45.92M |
| September 30, 2025 | 53.60M |
| June 30, 2025 | 62.63M |
| Date | Value |
|---|---|
| March 31, 2025 | 68.32M |
| December 31, 2024 | 76.39M |
| September 30, 2024 | 88.75M |
| June 30, 2024 | 96.13M |
| March 31, 2024 | 55.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 34.22M |
| BioNTech SE | 23.26B |
| Silence Therapeutics Plc | 106.41M |
| Autolus Therapeutics Plc | 493.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.062M |
| Shareholders Equity (Quarterly) | 28.65M |
| Debt to Equity Ratio | 0.0359 |
| Current Ratio | 5.884 |
| Net Debt Paydown Yield | -0.11% |